crwepicks'  Instablog

Send Message
My company:
  • New Up and Coming Company Plus Video Complimenbts of - True 2 Beauty Inc. TRTB.PK, SOLR, OVTI, SVNT 0 comments
    Oct 21, 2010 11:31 AM | about stocks: Q, OVTI, SVNTQ



    True 2 Beauty, Inc. (Pinksheets:TRTB)

    True 2 Beauty Inc. (Pinksheets:TRTB), a leading manufacturer and distributor of male sexual potency pills and liquid products in the United States, announced today the "Libigrow" family of products. has signed its first distribution agreement overseas.

    "Libi Grow International Limited," the distributor, will purchase a minimum of $500,000 of products and serve a distribution area including Great Britain & the Republic of Ireland, Italy, Turkey, Germany & Switzerland.

    Both companies have agreed to co-op advertising support and hyperlinks for their respective websites.

    Alex Hbaiu, President and CEO of True 2 Beauty Inc., stated, "This agreement is the first step in our efforts to bring the 'Libigrow' family of products to Europe and we are pleased to have strong local marketing experts to assist us."

    True 2 Beauty, Inc. is a leading manufacturer and distributor of male sexual potency pills and liquid products in the United States. The True 2 Beauty, Inc. line of current products includes Libigrow, Libigirl, Libiliquid Shots and the Libiliquid Relaxation Drink. More information on the Company and its line of products can be found at


    GT Solar International, Inc. (NASDAQ:SOLR), a global provider of polysilicon production technology, and sapphire and silicon crystalline growth systems and materials for the solar, LED and other specialty markets, announced on October 11, 2010 that it has opened its new Asia operations headquarters in Hong Kong. The Hong Kong headquarters better serves the needs of its customers throughout the Asia Pacific region.

    GT Solar International, Inc. is a global provider of polysilicon production technology, and sapphire and silicon crystalline growth systems and materials for the solar, LED and other specialty markets. The company's products and services allow its customers to optimize their manufacturing environments and lower their cost of ownership.


    OmniVision Technologies Inc. (NASDAQ:OVTI) a leading developer of advanced digital imaging solutions, announced on October 20, 2010 that its OV9715 automotive-grade megapixel sensor has been selected by Xilinx, Inc. for its four camera, 360-degree surround view automotive reference design. The Xilinx reference design highlights the advantages of megapixel resolution sensors over VGA-based systems for extreme wide-angle field of view applications, such as greatly improved image distortion correction and stitching. Designed to meet the stringent requirements of the automotive and sensing applications markets, the OV9715 also improves on obstacle and pedestrian detection by capturing more detailed scene information.

    OmniVision Technologies is a leading developer of advanced digital imaging solutions. Its award-winning CMOS imaging technology enables superior image quality in many of today's consumer and commercial applications, including mobile phones, notebooks and webcams, digital still and video cameras, security and surveillance, entertainment devices, automotive and medical imaging systems.


    Savient Pharmaceuticals, Inc. (NasdaqGM:SVNT) announced on September 30, 2010 that the United States District Court for the Southern District of New York has dismissed the Class Action originally filed on November 25, 2008, and captioned Richard Sagall vs. Savient Pharmaceuticals, Inc., et al., against the Company and two of its former officers. The suit alleged that the Company made false and misleading statements relating to the GOUT1 and GOUT2 phase 3 clinical trials and that the Company failed to disclose in a timely manner serious adverse events which occurred in five patients in these trials. The Company and the other named defendants had filed a motion to dismiss the complaint in June 2009.

    Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing KRYSTEXXA(NYSE:TM) (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient also manufactures and supplies Oxandrin(NYSE:R) (oxandrolone tablets, USP) CIII in the U.S.







    Sign-Up For Free Stock Alerts At

    business Card 3




    Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more at ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received four thousand dollars in cash from a third party (Trinity International, LLC) for 1 day advertisement services for True 2 Beauty Inc. (TRTB.PK).


    Stocks: Q, OVTI, SVNTQ
Back To crwepicks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.